Item does not contain fulltextBackground: Persistent attention deficit hyperactivity disorder (ADHD) and a history of conduct disorder (CD) are highly prevalent among patients with substance use disorders (SUD). We examined the influence of both diagnoses on problem severity, psychiatric comorbidity, and quality of life in methadone-maintained patients. Methods: 193 patients in long-term methadone maintenance treatment (MMT) were assessed for ADHD through a semi-structured interview. Psychiatric disorders and SUD were assessed with the MINI, the CIDI-SAM, and the SIDP-IV. Results: Childhood ADHD was diagnosed in 68 (35.2%) patients; 48 (24.9%) had persisting ADHD; a CD history was present in 116 (60.1%). Patients with adult ADHD had signifi...
Item does not contain fulltextAIMS: To determine comorbidity patterns in treatment-seeking substance...
AIMS: To determine comorbidity patterns in treatment-seeking substance use disorder (SUD) patients w...
Introduction and aims: Knowledge of ADHD symptoms among patients in opioid maintenance treatment (OM...
Item does not contain fulltextBACKGROUND: Persistent attention deficit hyperactivity disorder (ADHD)...
Background: Persistent attention deficit hyperactivity disorder (ADHD) and a history of conduct diso...
BACKGROUND: Persistent attention deficit hyperactivity disorder (ADHD) and a history of conduct diso...
This retrospective cross-sectional study examines whether conduct disorder and attention deficit hyp...
Introduction: Comorbid attention deficit/hyperactivity disorder (ADHD) is present in 15-25% of all p...
INTRODUCTION AND AIMS: Attention deficit hyperactivity disorder (ADHD) is a known risk factor for su...
BACKGROUND There is a lack of local research regarding the prevalence of adult Attention Deficit H...
Attention Deficit Hyperactivity Disorder (ADHD) is a risk for substance use disorders. The aim of th...
Contains fulltext : 81831.pdf (publisher's version ) (Closed access)Despite the ef...
Item does not contain fulltextDespite the efficacy of methadone maintenance treatment (MMT), opioid ...
Attention deficit hyperactivity disorder (ADHD) is a known risk factor for substance use disorder (S...
In cross-sectional studies, attention-deficit hyperactivity disorder (ADHD) in adults has been linke...
Item does not contain fulltextAIMS: To determine comorbidity patterns in treatment-seeking substance...
AIMS: To determine comorbidity patterns in treatment-seeking substance use disorder (SUD) patients w...
Introduction and aims: Knowledge of ADHD symptoms among patients in opioid maintenance treatment (OM...
Item does not contain fulltextBACKGROUND: Persistent attention deficit hyperactivity disorder (ADHD)...
Background: Persistent attention deficit hyperactivity disorder (ADHD) and a history of conduct diso...
BACKGROUND: Persistent attention deficit hyperactivity disorder (ADHD) and a history of conduct diso...
This retrospective cross-sectional study examines whether conduct disorder and attention deficit hyp...
Introduction: Comorbid attention deficit/hyperactivity disorder (ADHD) is present in 15-25% of all p...
INTRODUCTION AND AIMS: Attention deficit hyperactivity disorder (ADHD) is a known risk factor for su...
BACKGROUND There is a lack of local research regarding the prevalence of adult Attention Deficit H...
Attention Deficit Hyperactivity Disorder (ADHD) is a risk for substance use disorders. The aim of th...
Contains fulltext : 81831.pdf (publisher's version ) (Closed access)Despite the ef...
Item does not contain fulltextDespite the efficacy of methadone maintenance treatment (MMT), opioid ...
Attention deficit hyperactivity disorder (ADHD) is a known risk factor for substance use disorder (S...
In cross-sectional studies, attention-deficit hyperactivity disorder (ADHD) in adults has been linke...
Item does not contain fulltextAIMS: To determine comorbidity patterns in treatment-seeking substance...
AIMS: To determine comorbidity patterns in treatment-seeking substance use disorder (SUD) patients w...
Introduction and aims: Knowledge of ADHD symptoms among patients in opioid maintenance treatment (OM...